Patents Assigned to University
  • Patent number: 7598346
    Abstract: The invention relates to compositions including amino acid sequences isolated from fungal fermentation broths and methods for protecting a plant from a pathogen, particularly a fungal pathogen.
    Type: Grant
    Filed: May 15, 2007
    Date of Patent: October 6, 2009
    Assignees: Pioneer Hi-Bred International, Inc., E. I. du Pont de Nemours and Company, The Regents of the University of California
    Inventors: Daniel J. Altier, Virginia C. Crane, Irina Ellanskaya, Natalia Ellanskaya, legal representative, Jacob T. Gilliam, Jennie Hunter-Cevera, James K. Presnail, Eric J. Schepers, Carl R. Simmons, Tamas Torok, Nasser Yalpani
  • Patent number: 7598238
    Abstract: Fused-ring triazole compounds which inhibit proliferation of cells and exhibit a unique and intense fluorescence are provided. Also provided are methods for synthesizing these compounds and methods for using these compounds to inhibit cell proliferation and infection and to label and fluorescently detect selected molecules.
    Type: Grant
    Filed: July 28, 2006
    Date of Patent: October 6, 2009
    Assignees: University of Medicine and Dentistry of New Jersey, Rutgers, the State University, Lehigh University
    Inventors: Jeffrey D. Laskin, Ned Heindel, Diane Heck, Anna Marie Vetrano, Christophe Guillon, Peter DeMatteo
  • Patent number: 7598033
    Abstract: A peptide or protein microassay method and apparatus in which a wide variety of chromogenic or fluorogenic peptide or protein substrates of interest are individually suspended or dissolved in a hydrophilic carrier, with aliquots of each substrate being deposited in an array or microarray of reaction loci, or “dots.” Each dot, therefore, provides an individual reaction vessel containing the peptide or protein of interest, to which a biological sample may be applied for assay purposes. The sample is applied to the array or microarray of dots by one of a variety of focused sample application techniques, including aerosolizing or misting of the sample, or target application of the sample, onto each dot without creating fluid channels between the dots which would cause cross-contamination. In additional aspects, the present invention provides methods of transferring samples from an electrophoretic gel to a target plate for subsequent MALDI MS analysis.
    Type: Grant
    Filed: December 15, 2004
    Date of Patent: October 6, 2009
    Assignee: University of Pennsylvania
    Inventors: Scott L. Diamond, Dhaval Gosalia
  • Patent number: 7599072
    Abstract: There is provided a method of calculating physical properties of a periodic structure. At least one physical property related to reflectivity or transmittance of a periodic structure is measured, and then, at least one physical property related to reflectivity or transmittance of a virtual periodic structure is calculated to obtain corresponding physical properties from the virtual periodic structure. The at least one calculated physical property is compared with the at least one measured physical property. When the virtual periodic structure is horizontally divided into a plurality of layers, at least three substances can have horizontally repeated periods in the middle layers of the divided structure. In accordance with an embodiment of the present invention, the microscopic formation of the periodic structure including a native oxide layer formed on the periodic structure or an intentionally formed surface coating layer thereon can be nondestructively and accurately tested.
    Type: Grant
    Filed: February 20, 2008
    Date of Patent: October 6, 2009
    Assignee: University-Industry Cooperation Group of Kyung Hee University
    Inventors: Young Dong Kim, Jin Mo Chung, Seung Ho Han
  • Patent number: 7598223
    Abstract: Methods and compositions for producing target cell reactive lymphocytes, e.g., cytolytic T-lymphocytes, in a subject are provided. In practicing the subject methods, a lymphocyte population is contacted with an effective amount of a target cell peptide mixture of active and inactive peptides to produce lymphocytes reactive, e.g., cytolytic, for the target cell. Also provided are compositions, kits, and systems for practicing the subject methods. The subject invention finds use in a variety of different applications, including therapeutic applications.
    Type: Grant
    Filed: July 19, 2005
    Date of Patent: October 6, 2009
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Peter P. Lee, Tor B. Stuge
  • Patent number: 7598275
    Abstract: Methods are provided for induction of angiogenesis by administration of nicotine or other nicotine receptor agonist. Induction of angiogenesis by the methods of the invention can be used in therapeutic angiogenesis in, for example, treatment of ischemic syndromes such as coronary or peripheral arterial disease.
    Type: Grant
    Filed: April 13, 2006
    Date of Patent: October 6, 2009
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: John Cooke, James Jang, Phillip Tsao, Christopher Heeschen
  • Patent number: 7598323
    Abstract: A method of effecting cross-linking of a resin comprises generating vinyl sulfonyl moieties in situ with the resin, said sulfonyl moieties then undergoing a reaction which effects cross-linking of the resin. The vinyl sulfonyl moieties may be generated as a result of a loss of a liquid carrier for the resin to be cross-linked. The cross-linking reaction may result from reaction of the vinyl sulfonyl moieties with nucleophilic groups in the resin composition. The resin may be a co-polymer of a compound of formula (IV) with other olefinically unsaturated monomers.
    Type: Grant
    Filed: November 27, 2003
    Date of Patent: October 6, 2009
    Assignee: The University of Manchester
    Inventors: Peter A. Lovell, David J. Berrisford, Andrew Whiting
  • Patent number: 7598363
    Abstract: Robust nucleic acid arrays and lattices are assembled based on double crossover cohesion of polygonal units whose edges are composed of nucleic acid multi-crossover domains.
    Type: Grant
    Filed: June 9, 2005
    Date of Patent: October 6, 2009
    Assignee: New York University
    Inventors: Nadrian C. Seeman, Baoquan Ding, Pamela E. Constantinou, Tong Wang, Jens Kopatsch, Xiaoping Zhang, Ruojie Sha, Lisa Israel
  • Patent number: 7598668
    Abstract: An organic semiconductor device includes organic semiconductor layers (3, 4) and an electron injecting electrode (5) which is composed of MgAu alloy and injects electrons into the organic semiconductor layers (3, 4). The MgAu alloy forming the electron injecting electrode (5) may contain not more than 85 atom % of Au. The organic semiconductor device may further include a hole injecting electrode (2) for injecting holes into the organic semiconductor layers (3, 4). The electron injecting electrode and the hole injecting electrode are arranged apart from each other in such a manner that they fit to each other. The organic semiconductor device may further include a gate electrode which is arranged opposite, via an insulating film, to the region between the electron injecting electrode and the hole injecting electrode.
    Type: Grant
    Filed: August 25, 2004
    Date of Patent: October 6, 2009
    Assignees: Kyoto University, Pioneer Corporation, Hitachi, Ltd., Mitsubishi Chemical Corporation, Rohm Co., Ltd.
    Inventors: Takahito Oyamada, Chihaya Adachi
  • Patent number: 7597926
    Abstract: Lithium quinolate is an electroluminescent material which emits light in the blue region of the spectrum.
    Type: Grant
    Filed: May 27, 2005
    Date of Patent: October 6, 2009
    Assignee: South Bank University Enterprises Ltd.
    Inventor: Poopathy Kathirgamanathan
  • Patent number: 7598739
    Abstract: A plurality of linear current elements are configured about a specimen to be imaged. A current in each current element is controlled independent of a current in other current elements to select a gradient and to provide radio frequency shimming. Each current element is driven by a separate channel of a transmitter and connected to a separate channel of a multi-channel receiver. The impedance, and therefore, the current, in each current element is controlled mechanically or electrically.
    Type: Grant
    Filed: April 21, 2003
    Date of Patent: October 6, 2009
    Assignee: Regents of the University of Minnesota
    Inventors: John Thomas Vaughan, Jr., Kamil Ugurbil, Gregor Adriany
  • Patent number: 7598745
    Abstract: An apparatus (2) for measuring electrical conductivity in a material has a pair of electrically conducting elements (6), a first electrical conductor (9) coupled to the electrically conducting elements and coupling a first transformer core (10) and a second transformer core (12) to form a first current loop (8), and a second electrical conductor (17) of known resistance coupling the second transformer core (12) and a third transformer core (14) to form a second current loop (16).
    Type: Grant
    Filed: January 14, 2005
    Date of Patent: October 6, 2009
    Assignee: The University of Southern Queensland
    Inventors: Nigel Harold Hancock, Andrew Douglas Maxwell, Antonio Louis Ah Fock
  • Patent number: 7598028
    Abstract: The present invention relates to compositions and methods for the detecting, treating, and empirically investigating cellular proliferation disorders and cellular motility disorders. In particular, the present invention provides compositions and methods for using CXCL chemokines (e.g., CXCL1, CXCL5, CXCL6, CXCL12), CXCL receptors (e.g., CXCR1, CXCR2, CXCR4, CXCR7), and/or pathway related compounds (e.g., NF-kappaB, ERK ½, ELK-1) in the diagnosis, treatment, and empirical investigation of prostate disorders (e.g., prostate cancer, benign prostatic hypertrophy, prostatitis).
    Type: Grant
    Filed: November 28, 2007
    Date of Patent: October 6, 2009
    Assignee: The Regents of the University of Michigan
    Inventor: Jill A. Macoska
  • Patent number: 7598371
    Abstract: An immobilized metal affinity chromatography (IMAC) method for separating and/or purifying compounds containing a non-shielded purine or pyrimidine moiety or group such as nucleic acid, presumably through interaction with the abundant aromatic nitrogen atoms in the purine or pyrimidine moiety. The method can also be used to purify compounds containing purine or pyrimidine moieties where the purine and pyrimidine moieties are shielded from interaction with the column matrix from compounds containing a non-shielded purine or pyrimidine moiety or group. Thus, double-stranded plasmid and genomic DNA, which has no low binding affinity can be easily separated from RNA and/or oligonucleotides which bind strongly to metal-charged chelating matrices. IMAC columns clarify plasmid DNA from bacterial alkaline lysates, purify a ribozyme, and remove primers and other contaminants from PCR reactions. The metal ion affinity of yeast RNA decreases in the order: copper (II), nickel (II), zinc (II), and cobalt (II).
    Type: Grant
    Filed: November 6, 2001
    Date of Patent: October 6, 2009
    Assignee: University of Houston
    Inventors: Richard C. Willson, Jason C. Murphy
  • Patent number: 7597695
    Abstract: Instruments and methods for spinal stabilization are disclosed. In preferred embodiments, the invention provides greater stabilization of vertebral bodies through methods including combinations of external fixation systems and intervertebral implants to provide greater fusion stability, greater motion segment stability, faster fusion, reduced pain, reduced chance of migration, reduced chance of subsidence, etc.
    Type: Grant
    Filed: February 27, 2006
    Date of Patent: October 6, 2009
    Assignees: Zimmer Spine, Inc., University of Pittsburgh of the Commonwealth System of Higher Education
    Inventors: Daniel G. Schmiel, Rodney L. Houfburg, Daniel D. McPhillips, William C. Welch
  • Patent number: 7599059
    Abstract: A method for analyzing/monitoring the properties of species that are labeled with fluorophores. A detector is used to detect photons emitted from species that are labeled with one or more fluorophores and located in a confocal detection volume. The arrival time of each of the photons is determined. The interval of time between various photon pairs is then determined to provide photon pair intervals. The number of photons that have arrival times within the photon pair intervals is also determined. The photon pair intervals are then used in combination with the corresponding counts of intervening photons to analyze properties and interactions of the molecules including brightness, concentration, coincidence and transit time. The method can be used for analyzing single photon streams and multiple photon streams.
    Type: Grant
    Filed: July 25, 2003
    Date of Patent: October 6, 2009
    Assignee: The Regents of the University of California
    Inventors: Ted A. Laurence, Shimon Weiss
  • Patent number: 7599557
    Abstract: In a boundary active only scheme proposed by the present invention, only a cell in a boundary of region growth is brought into an active mode, and the other cells are brought into a standby mode. The respective cells perform state transition in parallel, and decision of the state transition performed for each clock cycle is not performed in a case where any of the three conditions that none of the adjacent cells is ignited, the cell itself is already ignited, and the cell already belongs to a certain divided region is satisfied. Therefore the number of simultaneously operating cells and that of coupling weight registers are minimized, and control is automatically executed to reduce power consumption.
    Type: Grant
    Filed: April 7, 2008
    Date of Patent: October 6, 2009
    Assignee: Hiroshima University
    Inventors: Tetsushi Koide, Hans Jurgen Mattausch, Takashi Morimoto, Youmei Harada
  • Patent number: 7598340
    Abstract: A hybridoma (termed “UIC2 hybridoma”, ATCC Accession No. HB11027) producing monoclonal antibodies (termed “UIC2 mAb”) directed against an extracellular domain of a cell surface P-glycoprotein antigen associated with multidrug resistance in primate cells was produced by fusing a human myeloma cell with a spleen cell derived from a BALB/c mouse immunized with syngeneic 3T3 fibroblasts previously transfected with the isolated human mdr1 cDNA. UIC2 mAb, thus produced, as well as fragments and recombinant derivatives thereof, may be used to detect and isolate multidrug resistant primate cells and human mdr1 gene products, and to reverse multidrug resistance in primate cells, including cells of multidrug resistant human tumors.
    Type: Grant
    Filed: November 12, 2002
    Date of Patent: October 6, 2009
    Assignee: The Board of Trustees of the University of Illinois
    Inventors: Eugene Metchetner, Igor B. Roninson
  • Patent number: D601712
    Type: Grant
    Filed: February 19, 2008
    Date of Patent: October 6, 2009
    Assignee: Universal Bio Research Co., Ltd.
    Inventor: Hideji Tajima
  • Patent number: RE40931
    Abstract: A method of isolating, purifying and recrystallizing substantially pure lutein, preferably from saponified marigold oleoresin in its pure free form, apart from chemical impurities and other carotenoids. Lutein may be used as an analytical standard or in cancer prevention trials and as a safe and effective color additive for human food.
    Type: Grant
    Filed: January 10, 2006
    Date of Patent: October 6, 2009
    Assignee: The Catholic University of America
    Inventor: Frederick Khachik